These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 18220660)

  • 1. Management of obesity in patients with type 2 diabetes mellitus.
    Gagliardi L; Wittert G
    Curr Diabetes Rev; 2007 May; 3(2):95-101. PubMed ID: 18220660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Weight Loss and the Prevention and Treatment of Type 2 Diabetes Using Lifestyle Therapy, Pharmacotherapy, and Bariatric Surgery: Mechanisms of Action.
    Grams J; Garvey WT
    Curr Obes Rep; 2015 Jun; 4(2):287-302. PubMed ID: 26627223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current and Emerging Pharmacotherapies for Weight Management in Prediabetes and Diabetes.
    Lau DC; Teoh H
    Can J Diabetes; 2015 Dec; 39 Suppl 5():S134-41. PubMed ID: 26654857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of obesity on diabetes mellitus and the role of bariatric surgery.
    Gill RS; Sharma AM; Gill SS; Birch DW; Karmali S
    Maturitas; 2011 Jun; 69(2):137-40. PubMed ID: 21493021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Current and Emerging Glucose-Lowering Drugs on Body Weight in Type 2 Diabetes.
    Lau DC; Teoh H
    Can J Diabetes; 2015 Dec; 39 Suppl 5():S148-54. PubMed ID: 26654858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in insulin resistance following bariatric surgery: role of caloric restriction and weight loss.
    Gumbs AA; Modlin IM; Ballantyne GH
    Obes Surg; 2005 Apr; 15(4):462-73. PubMed ID: 15946423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ipragliflozin Improves Hepatic Steatosis in Obese Mice and Liver Dysfunction in Type 2 Diabetic Patients Irrespective of Body Weight Reduction.
    Komiya C; Tsuchiya K; Shiba K; Miyachi Y; Furuke S; Shimazu N; Yamaguchi S; Kanno K; Ogawa Y
    PLoS One; 2016; 11(3):e0151511. PubMed ID: 26977813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promising new approaches.
    Reasner CA
    Diabetes Obes Metab; 1999 May; 1 Suppl 1():S41-8. PubMed ID: 11220287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-associated weight gain in obese type 2 diabetes mellitus patients: What can be done?
    Brown A; Guess N; Dornhorst A; Taheri S; Frost G
    Diabetes Obes Metab; 2017 Dec; 19(12):1655-1668. PubMed ID: 28509408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Is there a role for surgery in the treatment of type 2 diabetes?].
    Benedix F; Meyer F; Klose S; Stroh C; Lippert H
    Dtsch Med Wochenschr; 2014 Jan; 139(5):207-12. PubMed ID: 24449355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement.
    Avenell A; Broom J; Brown TJ; Poobalan A; Aucott L; Stearns SC; Smith WC; Jung RT; Campbell MK; Grant AM
    Health Technol Assess; 2004 May; 8(21):iii-iv, 1-182. PubMed ID: 15147610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How to fight obesity with antidiabetic drugs: targeting gut or kidney?
    Baretić M; Troskot R
    Minerva Endocrinol; 2015 Mar; 40(1):71-83. PubMed ID: 25366984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Managing type 2 diabetes mellitus in patients with obesity.
    Hauner H
    Treat Endocrinol; 2004; 3(4):223-32. PubMed ID: 16026105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Off-label use of exenatide for the management of insulin-resistant type 1 diabetes mellitus in an obese patient with human immunodeficiency virus infection.
    Sheffield CA; Kane MP; Busch RS
    Pharmacotherapy; 2007 Oct; 27(10):1449-55. PubMed ID: 17896900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of bariatric surgery on liver glucose metabolism in morbidly obese diabetic and non-diabetic patients.
    Immonen H; Hannukainen JC; Iozzo P; Soinio M; Salminen P; Saunavaara V; Borra R; Parkkola R; Mari A; Lehtimäki T; Pham T; Laine J; Kärjä V; Pihlajamäki J; Nelimarkka L; Nuutila P
    J Hepatol; 2014 Feb; 60(2):377-83. PubMed ID: 24060855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relevance of weight in the management of patients with type 2 diabetes mellitus: towards an adipocentric approach to diabetes.
    Gorgojo Martínez JJ
    Med Clin (Barc); 2016 Nov; 147 Suppl 1():8-16. PubMed ID: 28760227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Managing patients with type 2 diabetes and obesity.
    Wilding J
    Practitioner; 2015 Jan; 259(1778):25-8, 3. PubMed ID: 25726618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of pharmacotherapy on weight management in type 2 diabetes.
    Hauner H
    Int J Obes Relat Metab Disord; 1999 Jun; 23 Suppl 7():S12-7. PubMed ID: 10455466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men. A randomized, controlled trial.
    Ross R; Dagnone D; Jones PJ; Smith H; Paddags A; Hudson R; Janssen I
    Ann Intern Med; 2000 Jul; 133(2):92-103. PubMed ID: 10896648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.